| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.733 | 0.006 | 0.761 | Aldehyde oxidase inhibitor | 0.761 0.005 CID_6452830 | CID_6452830 | |
| 0.683 | 0.004 | 0.683 | GABA C receptor rho-3 antagonist | 0.619 0.005 CID_6452830 | ||
| 0.683 | 0.008 | 0.683 | 5 Hydroxytryptamine release stimulant | 0.603 0.014 CID_6452830 | ||
| 0.615 | 0.009 | 0.615 | 5 Hydroxytryptamine release inhibitor | 0.561 0.017 CID_6452830 | ||
| 0.539 | 0.004 | 0.547 | 5 Hydroxytryptamine uptake stimulant | 0.547 0.004 CID_6452830 | CID_6452830 | |
| 0.539 | 0.027 | 0.539 | Cholesterol antagonist | 0.506 0.032 CID_6452830 | ||
| 0.511 | 0.009 | 0.675 | Peroxidase inhibitor | 0.675 0.003 CID_6452830 | CID_6452830 | |
| 0.524 | 0.024 | 0.524 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.371 0.128 CID_6452830 | ||
| 0.534 | 0.049 | 0.534 | Caspase 9 stimulant | 0.508 0.057 CID_6452830 | ||
| 0.501 | 0.037 | 0.501 | Antiobesity | 0.265 0.143 CID_6452830 | ||
| 0.473 | 0.039 | 0.473 | Histamine release inhibitor | 0.459 0.046 CID_6452830 | ||
| 0.435 | 0.014 | 0.435 | Calcium channel activator | 0.396 0.026 CID_6452830 | ||
| 0.442 | 0.031 | 0.442 | Aryl hydrocarbon receptor agonist | 0.329 0.053 CID_6452830 | ||
| 0.403 | 0.004 | 0.479 | Succinate dehydrogenase inhibitor | 0.479 0.003 CID_6452830 | CID_6452830 | |
| 0.399 | 0.004 | 0.399 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.288 0.007 CID_6452830 | ||
| 0.403 | 0.009 | 0.403 | Alpha-N-acetylglucosaminidase inhibitor | 0.285 0.018 CID_6452830 | ||
| 0.39 | 0.005 | 0.674 | Cystathionine beta-synthase inhibitor | 0.674 0.002 CID_6452830 | CID_6452830 | |
| 0.409 | 0.025 | 0.409 | Superoxide dismutase inhibitor | 0.377 0.031 CID_6452830 | ||
| 0.366 | 0.013 | 0.366 | Tyrosine 3 hydroxylase inhibitor | 0.345 0.017 CID_6452830 | ||
| 0.37 | 0.021 | 0.37 | Anesthetic general | 0.3 0.033 CID_6452830 | ||
| 0.349 | 0.005 | 0.349 | Ferrochelatase inhibitor | 0.193 0.024 CID_6452830 | ||
| 0.363 | 0.022 | 0.363 | RNA-directed DNA polymerase inhibitor | 0.36 0.023 CID_6452830 | ||
| 0.321 | 0.008 | 0.321 | 3C-like protease (Human coronavirus) inhibitor | 0.236 0.034 CID_6452830 | ||
| 0.32 | 0.008 | 0.32 | GABA C receptor agonist | 0.235 0.015 CID_6452830 | ||
| 0.315 | 0.005 | 0.315 | GABA C receptor rho-2 antagonist | 0.252 0.011 CID_6452830 | ||
| 0.323 | 0.018 | 0.323 | 5 Hydroxytryptamine 1E antagonist | 0.303 0.028 CID_6452830 | ||
| 0.319 | 0.014 | 0.328 | Neurotrophic factor enhancer | 0.328 0.012 CID_6452830 | CID_6452830 | |
| 0.311 | 0.009 | 0.311 | Nitric-oxide synthase stimulant | 0.299 0.012 CID_6452830 | ||
| 0.335 | 0.033 | 0.335 | Sigma receptor agonist | 0.15 0.085 CID_6452830 | ||
| 0.303 | 0.005 | 0.303 | 5 Hydroxytryptamine 3E antagonist | 0.23 0.028 CID_6452830 | ||
| 0.368 | 0.078 | 0.368 | Calpain 2 inhibitor | 0.241 0.156 CID_6452830 | ||
| 0.291 | 0.004 | 0.291 | 5 Hydroxytryptamine 3A agonist | 0.242 0.006 CID_6452830 | ||
| 0.34 | 0.053 | 0.358 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.358 0.048 CID_6452830 | CID_6452830 | |
| 0.286 | 0.006 | 0.286 | Mannose-6-phosphate isomerase inhibitor | 0.285 0.006 CID_6452830 | ||
| 0.282 | 0.005 | 0.282 | Potassium channel large-conductance Ca-activated activator | 0.221 0.005 CID_6452830 | ||
| 0.316 | 0.039 | 0.316 | Psychostimulant | 0.195 0.082 CID_6452830 | ||
| 0.287 | 0.013 | 0.287 | Aldehyde dehydrogenase inhibitor | 0.255 0.017 CID_6452830 | ||
| 0.277 | 0.006 | 0.289 | Potassium channel (Ca-activated) activator | 0.289 0.005 CID_6452830 | CID_6452830 | |
| 0.279 | 0.008 | 0.279 | ATPase inhibitor | 0.234 0.018 CID_6452830 | ||
| 0.302 | 0.032 | 0.302 | Gastrin inhibitor | 0.215 0.126 CID_6452830 | ||
| 0.332 | 0.064 | 0.416 | 12-Lipoxygenase inhibitor | 0.416 0.035 CID_6452830 | CID_6452830 | |
| 0.271 | 0.004 | 0.278 | HIV-1 integrase (Overall Integration) inhibitor | 0.278 0.004 CID_6452830 | CID_6452830 | |
| 0.294 | 0.029 | 0.294 | Non-steroidal antiinflammatory agent | 0.26 0.039 CID_6452830 | ||
| 0.277 | 0.016 | 0.288 | NADPH oxidase inhibitor | 0.288 0.014 CID_6452830 | CID_6452830 | |
| 0.264 | 0.004 | 0.264 | Electrolyte absorption antagonist | 0.176 0.012 CID_6452830 | ||
| 0.263 | 0.005 | 0.312 | Creatine kinase inhibitor | 0.312 0.004 CID_6452830 | CID_6452830 | |
| 0.326 | 0.069 | 0.326 | Streptokinase A inhibitor | 0.285 0.085 CID_6452830 | ||
| 0.284 | 0.029 | 0.299 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.299 0.024 CID_6452830 | CID_6452830 | |
| 0.258 | 0.006 | 0.258 | GABA C receptor antagonist | 0.195 0.014 CID_6452830 | ||
| 0.298 | 0.049 | 0.298 | Interleukin agonist | 0.236 0.09 CID_6452830 | ||
| 0.251 | 0.004 | 0.251 | Glutamate release inhibitor | 0.207 0.005 CID_6452830 | ||
| 0.269 | 0.023 | 0.326 | Amylase inhibitor | 0.326 0.015 CID_6452830 | CID_6452830 | |
| 0.289 | 0.043 | 0.289 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.25 | 0.008 | 0.279 | NADH dehydrogenase inhibitor | 0.279 0.007 CID_6452830 | CID_6452830 | |
| 0.348 | 0.109 | 0.348 | Analgesic | |||
| 0.251 | 0.013 | 0.269 | UDP-glucose 4-epimerase inhibitor | 0.269 0.012 CID_6452830 | CID_6452830 | |
| 0.253 | 0.016 | 0.253 | Hexokinase inhibitor | 0.224 0.024 CID_6452830 | ||
| 0.271 | 0.037 | 0.271 | Neuropeptide Y2 antagonist | 0.235 0.071 CID_6452830 | ||
| 0.295 | 0.062 | 0.295 | Insulysin inhibitor | 0.28 0.072 CID_6452830 | ||
| 0.261 | 0.029 | 0.261 | Amyloid beta precursor protein antagonist | 0.205 0.054 CID_6452830 | ||
| 0.231 | 0.004 | 0.231 | Lanosterol 14 alpha demethylase inhibitor | 0.171 0.006 CID_6452830 | ||
| 0.24 | 0.013 | 0.24 | Carbonic anhydrase XV inhibitor | 0.206 0.018 CID_6452830 | ||
| 0.289 | 0.062 | 0.326 | Transcription factor STAT inhibitor | 0.326 0.043 CID_6452830 | CID_6452830 | |
| 0.277 | 0.051 | 0.277 | Cyclic AMP phosphodiesterase inhibitor | 0.213 0.085 CID_6452830 | ||
| 0.233 | 0.015 | 0.233 | Catenin beta inhibitor | 0.2 0.032 CID_6452830 | ||
| 0.222 | 0.005 | 0.222 | CYP2A6 inhibitor | 0.116 0.028 CID_6452830 | ||
| 0.28 | 0.064 | 0.28 | Transcription factor STAT3 inhibitor | 0.247 0.085 CID_6452830 | ||
| 0.227 | 0.011 | 0.227 | CF transmembrane conductance regulator agonist | 0.196 0.024 CID_6452830 | ||
| 0.222 | 0.006 | 0.222 | Sphingosine 1-phosphate receptor 4 antagonist | 0.187 0.012 CID_6452830 | ||
| 0.221 | 0.005 | 0.221 | GABA C receptor rho-1 antagonist | 0.16 0.018 CID_6452830 | ||
| 0.228 | 0.013 | 0.239 | Arachidonic acid antagonist | 0.239 0.008 CID_6452830 | CID_6452830 | |
| 0.239 | 0.029 | 0.239 | Cyclooxygenase inhibitor | 0.204 0.04 CID_6452830 | ||
| 0.23 | 0.021 | 0.23 | Cholesterol synthesis inhibitor | 0.216 0.023 CID_6452830 | ||
| 0.258 | 0.05 | 0.258 | MAP kinase kinase 2 inhibitor | 0.195 0.085 CID_6452830 | ||
| 0.295 | 0.092 | 0.295 | Vasodilator, coronary | 0.232 0.152 CID_6452830 | ||
| 0.223 | 0.02 | 0.223 | Glutamate receptor antagonist | 0.115 0.08 CID_6452830 | ||
| 0.208 | 0.009 | 0.208 | Pregnane X receptor agonist | 0.178 0.02 CID_6452830 | ||
| 0.207 | 0.011 | 0.221 | Interleukin 8 antagonist | 0.221 0.009 CID_6452830 | CID_6452830 | |
| 0.316 | 0.121 | 0.345 | 15-Lipoxygenase inhibitor | 0.345 0.102 CID_6452830 | CID_6452830 | |
| 0.203 | 0.008 | 0.203 | Cannabinoid receptor antagonist | 0.085 0.037 CID_6452830 | ||
| 0.293 | 0.1 | 0.293 | Vasodilator, peripheral | 0.231 0.143 CID_6452830 | ||
| 0.241 | 0.05 | 0.241 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.198 | 0.007 | 0.224 | DOPA decarboxylase inhibitor | 0.224 0.004 CID_6452830 | CID_6452830 | |
| 0.248 | 0.058 | 0.248 | Anticonvulsant | |||
| 0.206 | 0.017 | 0.206 | Cyclooxygenase 3 inhibitor | 0.192 0.022 CID_6452830 | ||
| 0.193 | 0.004 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.182 0.006 CID_6452830 | ||
| 0.244 | 0.055 | 0.26 | ErbB-1 antagonist | 0.26 0.047 CID_6452830 | CID_6452830 | |
| 0.2 | 0.011 | 0.2 | Sphingosine 1-phosphate receptor 5 antagonist | 0.186 0.019 CID_6452830 | ||
| 0.214 | 0.027 | 0.214 | Cyclooxygenase 2 inhibitor | 0.175 0.04 CID_6452830 | ||
| 0.251 | 0.065 | 0.271 | DNA synthesis inhibitor | 0.271 0.055 CID_6452830 | CID_6452830 | |
| 0.19 | 0.005 | 0.19 | Cannabinoid CB1 receptor antagonist | 0.077 0.029 CID_6452830 | ||
| 0.206 | 0.021 | 0.206 | Cathepsin H inhibitor | 0.139 0.055 CID_6452830 | ||
| 0.194 | 0.011 | 0.194 | Sphingomyelinase inhibitor | 0.156 0.022 CID_6452830 | ||
| 0.213 | 0.029 | 0.213 | Cyclooxygenase 1 inhibitor | 0.184 0.041 CID_6452830 | ||
| 0.213 | 0.03 | 0.213 | Nav1.2 sodium channel blocker | 0.133 0.07 CID_6452830 | ||
| 0.185 | 0.004 | 0.185 | Bromodomain-containing protein 2 inhibitor | 0.139 0.013 CID_6452830 | ||
| 0.191 | 0.012 | 0.191 | Triose-phosphate isomerase inhibitor | 0.138 0.024 CID_6452830 | ||
| 0.195 | 0.016 | 0.195 | Catalase inhibitor | 0.133 0.03 CID_6452830 | ||
| 0.205 | 0.027 | 0.205 | Sodium channel (voltage-gated) blocker | 0.141 0.062 CID_6452830 | ||
| 0.273 | 0.095 | 0.292 | Caspase 3 stimulant | 0.292 0.083 CID_6452830 | CID_6452830 | |
| 0.192 | 0.014 | 0.28 | Histidine decarboxylase inhibitor | 0.28 0.007 CID_6452830 | CID_6452830 | |
| 0.185 | 0.008 | 0.185 | Phenylalanine 4-hydroxylase inhibitor | 0.177 0.009 CID_6452830 | ||
| 0.216 | 0.039 | 0.216 | Diuretic | 0.204 0.043 CID_6452830 | ||
| 0.234 | 0.057 | 0.234 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.207 | 0.031 | 0.207 | Neurotensin receptor agonist | 0.205 0.032 CID_6452830 | ||
| 0.18 | 0.005 | 0.18 | Sphingosine 1-phosphate receptor 4 agonist | 0.161 0.007 CID_6452830 | ||
| 0.244 | 0.07 | 0.244 | Calpain inhibitor | 0.205 0.109 CID_6452830 | ||
| 0.202 | 0.029 | 0.211 | Cell wall synthesis inhibitor | 0.211 0.026 CID_6452830 | CID_6452830 | |
| 0.187 | 0.014 | 0.187 | TRPA1 agonist | 0.165 0.022 CID_6452830 | ||
| 0.194 | 0.021 | 0.194 | Nav1.6 sodium channel blocker | 0.144 0.062 CID_6452830 | ||
| 0.21 | 0.038 | 0.226 | Phospholipase C inhibitor | 0.226 0.031 CID_6452830 | CID_6452830 | |
| 0.223 | 0.052 | 0.223 | LIM domain kinase 1 inhibitor | 0.151 0.097 CID_6452830 | ||
| 0.202 | 0.032 | 0.202 | Interleukin 1 antagonist | |||
| 0.189 | 0.018 | 0.197 | Carbonic anhydrase III inhibitor | 0.197 0.017 CID_6452830 | CID_6452830 | |
| 0.184 | 0.014 | 0.184 | Porphobilinogen synthase inhibitor | 0.167 0.017 CID_6452830 | ||
| 0.212 | 0.043 | 0.347 | Heat shock protein 90 alpha antagonist | 0.347 0.009 CID_6452830 | CID_6452830 | |
| 0.194 | 0.026 | 0.194 | MAP kinase 3 inhibitor | 0.158 0.057 CID_6452830 | ||
| 0.276 | 0.109 | 0.353 | Transcription factor NF kappa B inhibitor | 0.353 0.076 CID_6452830 | CID_6452830 | |
| 0.173 | 0.007 | 0.173 | Prostaglandin E2 antagonist | |||
| 0.18 | 0.015 | 0.18 | Sphingosine 1-phosphate receptor 2 antagonist | 0.171 0.02 CID_6452830 | ||
| 0.231 | 0.067 | 0.281 | Pyruvate kinase inhibitor | 0.281 0.053 CID_6452830 | CID_6452830 | |
| 0.186 | 0.022 | 0.189 | Adenylate cyclase stimulant | 0.189 0.019 CID_6452830 | CID_6452830 | |
| 0.176 | 0.014 | 0.176 | Heat shock protein 70 antagonist | 0.163 0.024 CID_6452830 | ||
| 0.245 | 0.083 | 0.245 | DNA damaging | 0.207 0.11 CID_6452830 | ||
| 0.299 | 0.137 | 0.299 | MAP kinase kinase 6 inhibitor | |||
| 0.196 | 0.034 | 0.196 | Alkaline phosphatase inhibitor | 0.192 0.036 CID_6452830 | ||
| 0.188 | 0.029 | 0.188 | Nav1.3 sodium channel blocker | 0.122 0.072 CID_6452830 | ||
| 0.212 | 0.053 | 0.212 | Histone acetyltransferase inhibitor | 0.174 0.108 CID_6452830 | ||
| 0.163 | 0.005 | 0.163 | Glycine receptor antagonist | 0.139 0.01 CID_6452830 | ||
| 0.167 | 0.009 | 0.167 | Histamine N-methyltransferase inhibitor | 0.13 0.024 CID_6452830 | ||
| 0.195 | 0.039 | 0.195 | Cyclin-dependent kinase 8 inhibitor | 0.182 0.05 CID_6452830 | ||
| 0.16 | 0.005 | 0.16 | Aryl hydrocarbon receptor antagonist | 0.1 0.013 CID_6452830 | ||
| 0.253 | 0.098 | 0.267 | Hypoxia-inducible factor 1 alpha inhibitor | 0.267 0.085 CID_6452830 | CID_6452830 | |
| 0.27 | 0.117 | 0.358 | Prostaglandin dehydrogenase inhibitor | 0.358 0.08 CID_6452830 | CID_6452830 | |
| 0.172 | 0.019 | 0.181 | NMDA receptor antagonist | 0.181 0.017 CID_6452830 | CID_6452830 | |
| 0.267 | 0.113 | 0.267 | Antithrombotic | 0.216 0.158 CID_6452830 | ||
| 0.196 | 0.043 | 0.196 | Interleukin 6 antagonist | 0.14 0.105 CID_6452830 | ||
| 0.157 | 0.005 | 0.173 | D-Ala-D-Ala ligase inhibitor | 0.173 0.004 CID_6452830 | CID_6452830 | |
| 0.155 | 0.004 | 0.16 | GABA B receptor agonist | 0.16 0.004 CID_6452830 | CID_6452830 | |
| 0.2 | 0.049 | 0.2 | Antipruritic | 0.161 0.082 CID_6452830 | ||
| 0.194 | 0.043 | 0.2 | Interferon gamma antagonist | 0.2 0.041 CID_6452830 | CID_6452830 | |
| 0.191 | 0.042 | 0.191 | Death-associated protein kinase 2 inhibitor | 0.165 0.076 CID_6452830 | ||
| 0.156 | 0.007 | 0.156 | NMDA receptor agonist | 0.11 0.016 CID_6452830 | ||
| 0.197 | 0.049 | 0.197 | Cytidine deaminase inhibitor | |||
| 0.157 | 0.009 | 0.157 | Adrenaline uptake inhibitor | 0.058 0.047 CID_6452830 | ||
| 0.148 | 0.004 | 0.148 | Exportin-1 inhibitor | 0.105 0.007 CID_6452830 | ||
| 0.166 | 0.021 | 0.166 | Adenylate kinase inhibitor | 0.127 0.038 CID_6452830 | ||
| 0.151 | 0.008 | 0.151 | GABA aminotransferase inhibitor | 0.144 0.009 CID_6452830 | ||
| 0.147 | 0.004 | 0.147 | NMDA receptor glycine site agonist | 0.118 0.009 CID_6452830 | ||
| 0.148 | 0.006 | 0.233 | NMDA receptor subunit 3B antagonist | 0.233 0.004 CID_6452830 | CID_6452830 | |
| 0.194 | 0.053 | 0.194 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.162 | 0.021 | 0.162 | AMP-activated protein kinase stimulant | 0.156 0.024 CID_6452830 | ||
| 0.162 | 0.022 | 0.162 | Nav1.5 sodium channel blocker | 0.105 0.076 CID_6452830 | ||
| 0.147 | 0.007 | 0.147 | Glycine receptor agonist | 0.124 0.011 CID_6452830 | ||
| 0.18 | 0.041 | 0.18 | Sodium channel blocker | 0.117 0.088 CID_6452830 | ||
| 0.15 | 0.012 | 0.15 | Glutamate (mGluR7) agonist | 0.105 0.05 CID_6452830 | ||
| 0.246 | 0.107 | 0.246 | Ca(v)3.3 blocker | |||
| 0.153 | 0.015 | 0.153 | Acetylcholine release stimulant | 0.115 0.056 CID_6452830 | ||
| 0.142 | 0.005 | 0.142 | Potassium channel intermediate-conductance Ca-activated blocker | 0.068 0.029 CID_6452830 | ||
| 0.194 | 0.057 | 0.194 | Tumour necrosis factor antagonist | 0.14 0.113 CID_6452830 | ||
| 0.156 | 0.019 | 0.176 | Transcription factor STAT6 inhibitor | 0.176 0.011 CID_6452830 | CID_6452830 | |
| 0.178 | 0.041 | 0.259 | M18 aspartyl aminopeptidase inhibitor | 0.259 0.019 CID_6452830 | CID_6452830 | |
| 0.173 | 0.038 | 0.189 | Toll-Like receptor 2 antagonist | 0.189 0.029 CID_6452830 | CID_6452830 | |
| 0.144 | 0.011 | 0.144 | Alcohol oxidase inhibitor | 0.125 0.013 CID_6452830 | ||
| 0.145 | 0.013 | 0.145 | Prostaglandin-E synthase inhibitor | 0.112 0.022 CID_6452830 | ||
| 0.136 | 0.004 | 0.136 | Calcium channel P-type blocker | 0.092 0.008 CID_6452830 | ||
| 0.152 | 0.02 | 0.152 | Alcohol dehydrogenase inhibitor | 0.145 0.022 CID_6452830 | ||
| 0.152 | 0.02 | 0.152 | Potassium channel activator | 0.098 0.05 CID_6452830 | ||
| 0.153 | 0.021 | 0.173 | Urease inhibitor | 0.173 0.014 CID_6452830 | CID_6452830 | |
| 0.17 | 0.039 | 0.17 | Neuropeptide Y1 antagonist | 0.152 0.062 CID_6452830 | ||
| 0.136 | 0.004 | 0.136 | Vanilloid 4 agonist | 0.105 0.013 CID_6452830 | ||
| 0.135 | 0.004 | 0.135 | Phospholipase D inhibitor | 0.105 0.012 CID_6452830 | ||
| 0.139 | 0.01 | 0.139 | Dopamine D4 agonist | |||
| 0.157 | 0.027 | 0.157 | Photosensitizer | 0.132 0.045 CID_6452830 | ||
| 0.138 | 0.009 | 0.138 | Cannabinoid CB2 receptor antagonist | 0.092 0.017 CID_6452830 | ||
| 0.201 | 0.073 | 0.201 | Insulin sensitizer | 0.197 0.076 CID_6452830 | ||
| 0.159 | 0.031 | 0.159 | GABA receptor agonist | 0.097 0.081 CID_6452830 | ||
| 0.149 | 0.021 | 0.149 | Phosphodiesterase 7B inhibitor | |||
| 0.151 | 0.024 | 0.166 | Beta glucuronidase inhibitor | 0.166 0.019 CID_6452830 | CID_6452830 | |
| 0.138 | 0.011 | 0.138 | TRPA1 antagonist | 0.08 0.025 CID_6452830 | ||
| 0.236 | 0.11 | 0.304 | Lipoxygenase inhibitor | 0.304 0.069 CID_6452830 | CID_6452830 | |
| 0.144 | 0.018 | 0.152 | NMDA 2 receptor antagonist | 0.152 0.016 CID_6452830 | CID_6452830 | |
| 0.178 | 0.053 | 0.214 | Melanin inhibitor | 0.214 0.036 CID_6452830 | CID_6452830 | |
| 0.175 | 0.05 | 0.21 | MAO inhibitor | 0.21 0.038 CID_6452830 | CID_6452830 | |
| 0.175 | 0.051 | 0.175 | Thiol protease inhibitor | 0.138 0.083 CID_6452830 | ||
| 0.176 | 0.051 | 0.326 | Heat shock protein 90 antagonist | 0.326 0.007 CID_6452830 | CID_6452830 | |
| 0.157 | 0.033 | 0.157 | Falcipain 3 inhibitor | 0.088 0.083 CID_6452830 | ||
| 0.128 | 0.004 | 0.128 | Nicotinic alpha3beta2 receptor antagonist | 0.078 0.014 CID_6452830 | ||
| 0.143 | 0.019 | 0.143 | MAP kinase kinase 1 inhibitor | 0.131 0.026 CID_6452830 | ||
| 0.134 | 0.012 | 0.134 | Nicotinic alpha4beta2 receptor antagonist | 0.09 0.04 CID_6452830 | ||
| 0.186 | 0.064 | 0.202 | Mcl-1 antagonist | 0.202 0.054 CID_6452830 | CID_6452830 | |
| 0.13 | 0.008 | 0.13 | Bcl2 antagonist | 0.095 0.021 CID_6452830 | ||
| 0.19 | 0.069 | 0.19 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.126 | 0.005 | 0.126 | Glutamate (mGluR6) antagonist | 0.096 0.012 CID_6452830 | ||
| 0.169 | 0.049 | 0.169 | Hemostatic | 0.131 0.094 CID_6452830 | ||
| 0.132 | 0.012 | 0.132 | Benzodiazepine agonist | 0.066 0.058 CID_6452830 | ||
| 0.123 | 0.004 | 0.123 | MDM2 inhibitor | 0.106 0.005 CID_6452830 | ||
| 0.138 | 0.019 | 0.281 | Macrophage migration inhibitory factor inhibitor | 0.281 0.005 CID_6452830 | CID_6452830 | |
| 0.122 | 0.004 | 0.122 | Corticotropin releasing factor 2 receptor antagonist | 0.072 0.026 CID_6452830 | ||
| 0.149 | 0.032 | 0.149 | DNA repair enzyme inhibitor | 0.13 0.055 CID_6452830 | ||
| 0.13 | 0.012 | 0.13 | T cell inhibitor | 0.106 0.02 CID_6452830 | ||
| 0.13 | 0.013 | 0.13 | Dopamine uptake inhibitor | 0.074 0.028 CID_6452830 | ||
| 0.141 | 0.023 | 0.144 | Anabolic | 0.144 0.021 CID_6452830 | CID_6452830 | |
| 0.14 | 0.023 | 0.192 | Protein kinase C zeta inhibitor | 0.192 0.012 CID_6452830 | CID_6452830 | |
| 0.128 | 0.011 | 0.128 | Granulocyte macrophage colony stimulating factor agonist | 0.12 0.016 CID_6452830 | ||
| 0.273 | 0.157 | 0.33 | Antibacterial | 0.33 0.115 CID_6452830 | CID_6452830 | |
| 0.121 | 0.007 | 0.164 | NMDA receptor subunit 3A antagonist | 0.164 0.005 CID_6452830 | CID_6452830 | |
| 0.143 | 0.03 | 0.143 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.1 CID_6452830 | ||
| 0.125 | 0.013 | 0.125 | Biliverdin reductase inhibitor | 0.071 0.031 CID_6452830 | ||
| 0.143 | 0.032 | 0.143 | Falcipain 2 inhibitor | |||
| 0.144 | 0.033 | 0.144 | Falcipain inhibitor | |||
| 0.118 | 0.007 | 0.118 | Purinergic P2X antagonist | |||
| 0.204 | 0.093 | 0.204 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.129 | 0.018 | 0.129 | Glutathione S-transferase inhibitor | 0.099 0.038 CID_6452830 | ||
| 0.124 | 0.014 | 0.124 | Purinergic P2 antagonist | |||
| 0.119 | 0.009 | 0.119 | 5 Hydroxytryptamine 3 agonist | 0.073 0.033 CID_6452830 | ||
| 0.148 | 0.039 | 0.148 | Aminopeptidase B inhibitor | 0.11 0.058 CID_6452830 | ||
| 0.12 | 0.011 | 0.12 | Purinergic P2X1 antagonist | 0.115 0.013 CID_6452830 | ||
| 0.152 | 0.044 | 0.152 | Antibacterial (Helicobacter pylori) | 0.109 0.099 CID_6452830 | ||
| 0.123 | 0.016 | 0.123 | Nav1.7 sodium channel blocker | 0.073 0.04 CID_6452830 | ||
| 0.111 | 0.004 | 0.111 | Potassium channel small-conductance Ca-activated activator | 0.033 0.02 CID_6452830 | ||
| 0.122 | 0.015 | 0.122 | Carbamoyl phosphate synthetase inhibitor | 0.092 0.023 CID_6452830 | ||
| 0.143 | 0.036 | 0.143 | Protein kinase C gamma inhibitor | 0.108 0.065 CID_6452830 | ||
| 0.188 | 0.082 | 0.188 | I kappa B kinase epsilon inhibitor | |||
| 0.164 | 0.059 | 0.164 | Protein kinase stimulant | 0.153 0.066 CID_6452830 | ||
| 0.184 | 0.078 | 0.217 | DNA methyltransferase I inhibitor | 0.217 0.061 CID_6452830 | CID_6452830 | |
| 0.117 | 0.012 | 0.117 | Acetylcholine M5 receptor agonist | 0.063 0.052 CID_6452830 | ||
| 0.115 | 0.009 | 0.115 | Dopamine transporter inhibitor | 0.048 0.034 CID_6452830 | ||
| 0.214 | 0.109 | 0.214 | Spasmolytic | 0.194 0.125 CID_6452830 | ||
| 0.115 | 0.01 | 0.115 | NMDA 2A receptor antagonist | 0.099 0.013 CID_6452830 | ||
| 0.144 | 0.039 | 0.178 | MAO B inhibitor | 0.178 0.029 CID_6452830 | CID_6452830 | |
| 0.125 | 0.02 | 0.125 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.127 | 0.023 | 0.127 | Phosphofructokinase-1 inhibitor | 0.106 0.029 CID_6452830 | ||
| 0.14 | 0.036 | 0.14 | Chemokine receptor antagonist | |||
| 0.112 | 0.008 | 0.112 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.085 0.029 CID_6452830 | ||
| 0.127 | 0.027 | 0.127 | Carbonic anhydrase VI inhibitor | 0.121 0.029 CID_6452830 | ||
| 0.147 | 0.047 | 0.202 | Adenylate cyclase inhibitor | 0.202 0.025 CID_6452830 | CID_6452830 | |
| 0.105 | 0.004 | 0.105 | Potassium channel (Inward rectifier) activator | 0.07 0.011 CID_6452830 | ||
| 0.131 | 0.031 | 0.131 | Prolactin inhibitor | 0.12 0.038 CID_6452830 | ||
| 0.104 | 0.004 | 0.104 | Adenylate cyclase 1 inhibitor | 0.083 0.007 CID_6452830 | ||
| 0.188 | 0.088 | 0.208 | DNA methylase inhibitor | 0.208 0.074 CID_6452830 | CID_6452830 | |
| 0.13 | 0.03 | 0.13 | Calcium antagonist | |||
| 0.116 | 0.017 | 0.116 | Amidase inhibitor | 0.093 0.029 CID_6452830 | ||
| 0.11 | 0.011 | 0.11 | 5 Hydroxytryptamine 2A agonist | 0.09 0.019 CID_6452830 | ||
| 0.103 | 0.005 | 0.103 | Bromodomain-containing protein 3 inhibitor | 0.044 0.043 CID_6452830 | ||
| 0.139 | 0.041 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.03 CID_6452830 | CID_6452830 | |
| 0.14 | 0.041 | 0.14 | MAP kinase 13 inhibitor | |||
| 0.136 | 0.038 | 0.141 | CDK3/cyclin E inhibitor | 0.141 0.033 CID_6452830 | CID_6452830 | |
| 0.141 | 0.043 | 0.141 | Alpha 2b adrenoreceptor antagonist | 0.098 0.077 CID_6452830 | ||
| 0.106 | 0.008 | 0.106 | 5 Hydroxytryptamine 2 agonist | 0.087 0.012 CID_6452830 | ||
| 0.102 | 0.004 | 0.102 | Potassium channel (ATP-sensitive) activator | 0.067 0.011 CID_6452830 | ||
| 0.13 | 0.032 | 0.13 | DNA directed RNA polymerase inhibitor | |||
| 0.12 | 0.023 | 0.12 | Glutamate dehydrogenase inhibitor | 0.096 0.032 CID_6452830 | ||
| 0.107 | 0.009 | 0.229 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.229 0.003 CID_6452830 | CID_6452830 | |
| 0.102 | 0.005 | 0.102 | Purinergic P2X4 antagonist | 0.088 0.005 CID_6452830 | ||
| 0.105 | 0.008 | 0.105 | Aconitate hydratase inhibitor | 0.069 0.019 CID_6452830 | ||
| 0.102 | 0.004 | 0.102 | CC chemokine 4 receptor antagonist | 0.06 0.016 CID_6452830 | ||
| 0.11 | 0.013 | 0.11 | NMDA 2C receptor antagonist | 0.103 0.015 CID_6452830 | ||
| 0.124 | 0.027 | 0.149 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.149 0.019 CID_6452830 | CID_6452830 | |
| 0.124 | 0.028 | 0.124 | Carbonic anhydrase XIII inhibitor | 0.115 0.031 CID_6452830 | ||
| 0.117 | 0.021 | 0.117 | Myeloperoxidase inhibitor | 0.106 0.029 CID_6452830 | ||
| 0.118 | 0.022 | 0.118 | Bile acid receptor antagonist | 0.115 0.024 CID_6452830 | ||
| 0.129 | 0.034 | 0.129 | Hedgehog signaling inhibitor | |||
| 0.098 | 0.004 | 0.101 | Pregnane X receptor antagonist | 0.101 0.004 CID_6452830 | CID_6452830 | |
| 0.101 | 0.007 | 0.101 | 5 Hydroxytryptamine 7 agonist | 0.07 0.019 CID_6452830 | ||
| 0.119 | 0.025 | 0.119 | Inducible nitric-oxide synthase inhibitor | 0.076 0.07 CID_6452830 | ||
| 0.101 | 0.008 | 0.101 | Sphingosine kinase 2 inhibitor | 0.082 0.014 CID_6452830 | ||
| 0.097 | 0.005 | 0.097 | Dihydroorotate oxidase inhibitor | 0.082 0.01 CID_6452830 | ||
| 0.097 | 0.005 | 0.097 | GABA B receptor antagonist | 0.058 0.013 CID_6452830 | ||
| 0.14 | 0.048 | 0.14 | Beta amyloid protein antagonist | |||
| 0.113 | 0.021 | 0.113 | mTOR complex 2 inhibitor | 0.089 0.05 CID_6452830 | ||
| 0.122 | 0.03 | 0.122 | Potassium channel (Voltage-sensitive) activator | |||
| 0.223 | 0.132 | 0.223 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.118 | 0.027 | 0.118 | Glutamate receptor agonist | |||
| 0.102 | 0.013 | 0.102 | Phosphorylase inhibitor | 0.067 0.021 CID_6452830 | ||
| 0.143 | 0.055 | 0.143 | MAP kinase kinase inhibitor | 0.135 0.061 CID_6452830 | ||
| 0.102 | 0.014 | 0.102 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.073 0.024 CID_6452830 | ||
| 0.098 | 0.01 | 0.098 | Botulinum neurotoxin type A inhibitor | 0.084 0.015 CID_6452830 | ||
| 0.092 | 0.005 | 0.12 | Dopamine D5 agonist | 0.12 0.004 CID_6452830 | CID_6452830 | |
| 0.155 | 0.067 | 0.155 | NOS3 expression enhancer | 0.148 0.074 CID_6452830 | ||
| 0.098 | 0.012 | 0.098 | Glutamate (mGluR7) antagonist | 0.077 0.032 CID_6452830 | ||
| 0.091 | 0.005 | 0.091 | Glutamate (mGluR3) antagonist | 0.053 0.011 CID_6452830 | ||
| 0.102 | 0.016 | 0.102 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.034 CID_6452830 | ||
| 0.09 | 0.004 | 0.09 | Alpha 1d adrenoreceptor agonist | 0.051 0.016 CID_6452830 | ||
| 0.11 | 0.024 | 0.11 | Glutamate decarboxylase inhibitor | 0.105 0.027 CID_6452830 | ||
| 0.092 | 0.006 | 0.092 | Factor XIa inhibitor | |||
| 0.13 | 0.045 | 0.13 | EphA2 antagonist | 0.127 0.047 CID_6452830 | ||
| 0.177 | 0.091 | 0.177 | Focal adhesion kinase 2 inhibitor | |||
| 0.089 | 0.004 | 0.089 | Nerve growth factor antagonist | 0.069 0.005 CID_6452830 | ||
| 0.132 | 0.047 | 0.167 | MAO A inhibitor | 0.167 0.037 CID_6452830 | CID_6452830 | |
| 0.148 | 0.064 | 0.148 | Cytokine production inhibitor | |||
| 0.089 | 0.004 | 0.089 | 5 Hydroxytryptamine 2B agonist | 0.052 0.012 CID_6452830 | ||
| 0.113 | 0.029 | 0.113 | Interleukin 5 antagonist | |||
| 0.19 | 0.107 | 0.202 | Antiamyloidogenic | 0.202 0.098 CID_6452830 | CID_6452830 | |
| 0.102 | 0.019 | 0.102 | CC chemokine 5 receptor agonist | 0.096 0.026 CID_6452830 | ||
| 0.086 | 0.004 | 0.086 | Kynurenine 3 monooxygenase inhibitor | 0.064 0.005 CID_6452830 | ||
| 0.085 | 0.004 | 0.085 | Alpha 1L adrenoreceptor agonist | 0.044 0.026 CID_6452830 | ||
| 0.094 | 0.013 | 0.094 | Potassium channel (Tandem pore domain) blocker | |||
| 0.089 | 0.008 | 0.089 | Kallikrein 7 inhibitor | |||
| 0.101 | 0.021 | 0.101 | Sphingosine 1-phosphate receptor antagonist | 0.096 0.024 CID_6452830 | ||
| 0.085 | 0.004 | 0.085 | p53 inhibitor | 0.045 0.017 CID_6452830 | ||
| 0.102 | 0.022 | 0.109 | Estrogen-related receptor beta agonist | 0.109 0.016 CID_6452830 | CID_6452830 | |
| 0.085 | 0.005 | 0.085 | Benzodiazepine antagonist | 0.049 0.03 CID_6452830 | ||
| 0.084 | 0.004 | 0.084 | Heme oxygenase inhibitor | 0.056 0.008 CID_6452830 | ||
| 0.222 | 0.143 | 0.222 | Thyroid hormone antagonist | 0.221 0.144 CID_6452830 | ||
| 0.096 | 0.018 | 0.096 | Prostaglandin antagonist | |||
| 0.218 | 0.14 | 0.218 | Thyroid hormone beta antagonist | 0.208 0.147 CID_6452830 | ||
| 0.117 | 0.04 | 0.117 | Nitric-oxide synthase inhibitor | |||
| 0.166 | 0.089 | 0.166 | CDC-like kinase 4 inhibitor | |||
| 0.08 | 0.004 | 0.098 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.098 0.003 CID_6452830 | CID_6452830 | |
| 0.116 | 0.039 | 0.116 | Interleukin 1 beta converting enzyme inhibitor | 0.094 0.065 CID_6452830 | ||
| 0.129 | 0.053 | 0.129 | Calcium channel N-type blocker | |||
| 0.093 | 0.017 | 0.093 | GABA receptor antagonist | 0.05 0.044 CID_6452830 | ||
| 0.107 | 0.031 | 0.107 | Cathepsin G inhibitor | 0.064 0.061 CID_6452830 | ||
| 0.093 | 0.018 | 0.093 | GABA A receptor antagonist | 0.047 0.045 CID_6452830 | ||
| 0.093 | 0.018 | 0.093 | Carbonic anhydrase VB inhibitor | 0.062 0.033 CID_6452830 | ||
| 0.149 | 0.075 | 0.155 | Phospholipase A2 inhibitor | 0.155 0.069 CID_6452830 | CID_6452830 | |
| 0.12 | 0.045 | 0.12 | Interleukin 2 antagonist | |||
| 0.101 | 0.027 | 0.101 | Aminopeptidase I inhibitor | 0.076 0.046 CID_6452830 | ||
| 0.127 | 0.054 | 0.127 | Microtubule formation inhibitor | 0.125 0.055 CID_6452830 | ||
| 0.088 | 0.015 | 0.088 | Fatty acid synthase inhibitor | 0.073 0.023 CID_6452830 | ||
| 0.094 | 0.022 | 0.094 | Secretase beta inhibitor | |||
| 0.094 | 0.022 | 0.094 | Cannabinoid CB1 receptor agonist | |||
| 0.078 | 0.006 | 0.078 | Sirtuin 2 inhibitor | 0.047 0.014 CID_6452830 | ||
| 0.125 | 0.053 | 0.125 | Caspase 3 inhibitor | 0.098 0.096 CID_6452830 | ||
| 0.1 | 0.028 | 0.1 | Caspase 7 inhibitor | |||
| 0.104 | 0.032 | 0.104 | CC chemokine receptor antagonist | |||
| 0.076 | 0.004 | 0.189 | ATP citrate lysase inhibitor | 0.189 0.002 CID_6452830 | CID_6452830 | |
| 0.092 | 0.021 | 0.092 | Potassium channel Kv1.5 blocker | |||
| 0.129 | 0.059 | 0.129 | MAP kinase 12 inhibitor | |||
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_6452830 | ||
| 0.092 | 0.023 | 0.153 | Aromatase inhibitor | 0.153 0.013 CID_6452830 | CID_6452830 | |
| 0.085 | 0.016 | 0.085 | Phosphodiesterase 1C inhibitor | 0.062 0.044 CID_6452830 | ||
| 0.177 | 0.109 | 0.177 | Potassium channel blocker | |||
| 0.154 | 0.085 | 0.154 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.088 | 0.019 | 0.088 | Alpha 2 adrenoreceptor agonist | 0.055 0.05 CID_6452830 | ||
| 0.096 | 0.028 | 0.096 | Transforming growth factor beta 3 antagonist | |||
| 0.094 | 0.026 | 0.094 | I kappa B kinase 1 inhibitor | 0.079 0.038 CID_6452830 | ||
| 0.077 | 0.009 | 0.077 | Fructose-1,6-bisphosphatase inhibitor | 0.061 0.017 CID_6452830 | ||
| 0.146 | 0.078 | 0.146 | Acetylcholine M1 receptor antagonist | |||
| 0.077 | 0.009 | 0.077 | Dihydroorotase inhibitor | 0.058 0.018 CID_6452830 | ||
| 0.135 | 0.067 | 0.135 | Death-associated protein kinase 1 inhibitor | 0.132 0.075 CID_6452830 | ||
| 0.117 | 0.05 | 0.14 | Protein kinase (CK2) inhibitor | 0.14 0.037 CID_6452830 | CID_6452830 | |
| 0.095 | 0.027 | 0.095 | Carbonic anhydrase VA inhibitor | 0.068 0.049 CID_6452830 | ||
| 0.084 | 0.017 | 0.107 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.107 0.008 CID_6452830 | CID_6452830 | |
| 0.096 | 0.029 | 0.217 | Estrogen receptor alpha antagonist | 0.217 0.007 CID_6452830 | CID_6452830 | |
| 0.142 | 0.075 | 0.142 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.076 | 0.009 | 0.076 | Glutamate (mGluR4) antagonist | 0.043 0.031 CID_6452830 | ||
| 0.078 | 0.011 | 0.078 | Aldosterone antagonist | 0.052 0.026 CID_6452830 | ||
| 0.096 | 0.03 | 0.113 | Cyclin B3 inhibitor | 0.113 0.023 CID_6452830 | CID_6452830 | |
| 0.095 | 0.029 | 0.107 | Carbonic anhydrase V inhibitor | 0.107 0.025 CID_6452830 | CID_6452830 | |
| 0.082 | 0.017 | 0.082 | Dihydroorotate dehydrogenase inhibitor | 0.072 0.021 CID_6452830 | ||
| 0.14 | 0.075 | 0.14 | Activin receptor-like kinase 2 inhibitor | |||
| 0.071 | 0.006 | 0.071 | Potassium channel Kv1.1 blocker | 0.036 0.03 CID_6452830 | ||
| 0.071 | 0.006 | 0.071 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.062 0.007 CID_6452830 | ||
| 0.075 | 0.01 | 0.075 | Glucose-6-phosphate isomerase inhibitor | 0.065 0.015 CID_6452830 | ||
| 0.107 | 0.042 | 0.129 | Androgen antagonist | 0.129 0.029 CID_6452830 | CID_6452830 | |
| 0.073 | 0.008 | 0.073 | Kainate receptor 2 antagonist | 0.031 0.029 CID_6452830 | ||
| 0.081 | 0.016 | 0.081 | Transcription factor RelA inhibitor | 0.074 0.024 CID_6452830 | ||
| 0.086 | 0.022 | 0.108 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.108 0.014 CID_6452830 | CID_6452830 | |
| 0.076 | 0.012 | 0.076 | Glutamate (mGluR5) agonist | |||
| 0.078 | 0.014 | 0.078 | Sphingosine 1-phosphate receptor 1 antagonist | 0.074 0.016 CID_6452830 | ||
| 0.08 | 0.017 | 0.08 | Glycine transporter inhibitor | |||
| 0.082 | 0.019 | 0.169 | Heat shock protein 90 beta antagonist | 0.169 0.004 CID_6452830 | CID_6452830 | |
| 0.073 | 0.01 | 0.073 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.123 | 0.06 | 0.142 | Protein kinase (CK2) alpha inhibitor | 0.142 0.046 CID_6452830 | CID_6452830 | |
| 0.13 | 0.067 | 0.146 | Vanilloid 1 agonist | 0.146 0.042 CID_6452830 | CID_6452830 | |
| 0.096 | 0.035 | 0.096 | Protein kinase B gamma inhibitor | |||
| 0.065 | 0.004 | 0.065 | Vanilloid 3 antagonist | 0.046 0.012 CID_6452830 | ||
| 0.083 | 0.022 | 0.099 | Androgen agonist | 0.099 0.015 CID_6452830 | CID_6452830 | |
| 0.07 | 0.01 | 0.07 | Cholesterol esterase inhibitor | 0.05 0.03 CID_6452830 | ||
| 0.075 | 0.015 | 0.075 | Topoisomerase II beta inhibitor | 0.072 0.016 CID_6452830 | ||
| 0.082 | 0.022 | 0.082 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.248 | 0.188 | 0.248 | Transcription factor inhibitor | |||
| 0.072 | 0.013 | 0.072 | Squalene epoxidase inhibitor | 0.059 0.021 CID_6452830 | ||
| 0.064 | 0.005 | 0.064 | Kainate receptor agonist | 0.052 0.012 CID_6452830 | ||
| 0.121 | 0.062 | 0.121 | Interleukin 1b antagonist | |||
| 0.067 | 0.008 | 0.067 | Purinergic P2X7 antagonist | |||
| 0.074 | 0.014 | 0.074 | DNA helicase inhibitor | 0.064 0.022 CID_6452830 | ||
| 0.065 | 0.006 | 0.065 | Integrin alpha2 antagonist | 0.042 0.018 CID_6452830 | ||
| 0.074 | 0.015 | 0.074 | Glutamate (mGluR group I) agonist | |||
| 0.111 | 0.052 | 0.145 | Xanthine oxidase inhibitor | 0.145 0.037 CID_6452830 | CID_6452830 | |
| 0.089 | 0.03 | 0.089 | Dopamine D4 antagonist | 0.07 0.036 CID_6452830 | ||
| 0.062 | 0.004 | 0.062 | Alpha 2a adrenoreceptor agonist | 0.031 0.005 CID_6452830 | ||
| 0.068 | 0.009 | 0.072 | Dopamine beta hydroxylase inhibitor | 0.072 0.007 CID_6452830 | CID_6452830 | |
| 0.076 | 0.018 | 0.076 | Glucosylceramidase inhibitor | 0.052 0.044 CID_6452830 | ||
| 0.134 | 0.075 | 0.157 | Farnesoid X receptor antagonist | 0.157 0.045 CID_6452830 | CID_6452830 | |
| 0.072 | 0.014 | 0.072 | 5 Hydroxytryptamine 2C agonist | 0.039 0.038 CID_6452830 | ||
| 0.074 | 0.015 | 0.074 | Potassium channel (Inward rectifier) blocker | |||
| 0.068 | 0.009 | 0.068 | Liver X receptor alpha agonist | 0.067 0.01 CID_6452830 | ||
| 0.087 | 0.029 | 0.093 | MAP kinase kinase 7 inhibitor | 0.093 0.02 CID_6452830 | CID_6452830 | |
| 0.079 | 0.021 | 0.079 | Thromboxane antagonist | 0.059 0.033 CID_6452830 | ||
| 0.07 | 0.012 | 0.07 | Kainate receptor antagonist | 0.036 0.033 CID_6452830 | ||
| 0.132 | 0.075 | 0.132 | Toll-Like receptor 9 antagonist | |||
| 0.113 | 0.055 | 0.113 | MAP kinase kinase kinase inhibitor | |||
| 0.064 | 0.006 | 0.064 | Histamine H1 receptor agonist | |||
| 0.065 | 0.008 | 0.065 | Diamine oxidase inhibitor | |||
| 0.077 | 0.02 | 0.077 | Cyclin D1 inhibitor | 0.058 0.046 CID_6452830 | ||
| 0.15 | 0.093 | 0.15 | CDC-like kinase 2 inhibitor | |||
| 0.062 | 0.005 | 0.062 | Protein kinase (CK2) beta inhibitor | 0.046 0.009 CID_6452830 | ||
| 0.086 | 0.03 | 0.23 | Dopamine D1 antagonist | 0.23 0.009 CID_6452830 | CID_6452830 | |
| 0.071 | 0.015 | 0.071 | Glutamate (mGluR group III) agonist | 0.055 0.021 CID_6452830 | ||
| 0.081 | 0.025 | 0.081 | Argininosuccinate synthase inhibitor | 0.056 0.04 CID_6452830 | ||
| 0.075 | 0.019 | 0.075 | Sphingosine kinase inhibitor | 0.062 0.035 CID_6452830 | ||
| 0.064 | 0.009 | 0.064 | GABA uptake inhibitor | 0.045 0.02 CID_6452830 | ||
| 0.072 | 0.016 | 0.072 | Epithelial sodium channel blocker | 0.051 0.047 CID_6452830 | ||
| 0.06 | 0.004 | 0.073 | CF transmembrane conductance regulator antagonist | 0.073 0.004 CID_6452830 | CID_6452830 | |
| 0.076 | 0.02 | 0.076 | Sphingosine 1-phosphate receptor 3 antagonist | 0.064 0.032 CID_6452830 | ||
| 0.168 | 0.112 | 0.168 | HERG channel blocker | |||
| 0.06 | 0.005 | 0.06 | NMDA receptor glycine site antagonist | 0.051 0.005 CID_6452830 | ||
| 0.139 | 0.084 | 0.139 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.094 | 0.039 | 0.094 | MAP kinase 11 inhibitor | |||
| 0.061 | 0.007 | 0.061 | Factor XI inhibitor | |||
| 0.095 | 0.041 | 0.095 | Acetylcholine nicotinic agonist | |||
| 0.131 | 0.078 | 0.157 | Glycogen synthase kinase-3 alpha inhibitor | 0.157 0.062 CID_6452830 | CID_6452830 | |
| 0.058 | 0.004 | 0.058 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.009 CID_6452830 | ||
| 0.088 | 0.034 | 0.088 | Adenosine A3 receptor antagonist | 0.069 0.06 CID_6452830 | ||
| 0.117 | 0.064 | 0.117 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.062 | 0.009 | 0.062 | Farnesoid X receptor agonist | 0.047 0.017 CID_6452830 | ||
| 0.086 | 0.033 | 0.086 | Calcium channel L-type blocker | |||
| 0.072 | 0.02 | 0.072 | Thromboxane A2 antagonist | 0.057 0.031 CID_6452830 | ||
| 0.057 | 0.004 | 0.057 | Ceramide glucosyltransferase inhibitor | 0.054 0.005 CID_6452830 | ||
| 0.058 | 0.006 | 0.079 | Liver X receptor beta antagonist | 0.079 0.004 CID_6452830 | CID_6452830 | |
| 0.057 | 0.005 | 0.057 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.068 | 0.016 | 0.072 | CD45 antagonist | 0.072 0.014 CID_6452830 | CID_6452830 | |
| 0.063 | 0.012 | 0.063 | Glutamate (mGluR group III) antagonist | 0.042 0.035 CID_6452830 | ||
| 0.101 | 0.05 | 0.101 | Phosphodiesterase 6D inhibitor | |||
| 0.066 | 0.014 | 0.066 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.091 | 0.04 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.086 0.045 CID_6452830 | ||
| 0.126 | 0.076 | 0.126 | Toll-Like receptor antagonist | |||
| 0.06 | 0.01 | 0.06 | AMPA 4 receptor antagonist | 0.042 0.024 CID_6452830 | ||
| 0.059 | 0.009 | 0.071 | Liver X receptor beta agonist | 0.071 0.007 CID_6452830 | CID_6452830 | |
| 0.055 | 0.005 | 0.055 | LFA antagonist | |||
| 0.065 | 0.016 | 0.065 | Heparanase inhibitor | 0.057 0.029 CID_6452830 | ||
| 0.057 | 0.008 | 0.057 | Delayed rectifier potassium channel blocker | 0.041 0.021 CID_6452830 | ||
| 0.128 | 0.079 | 0.128 | Calcium channel blocker | |||
| 0.088 | 0.039 | 0.088 | Acetylcholine M4 receptor antagonist | |||
| 0.097 | 0.048 | 0.097 | Phosphodiesterase I inhibitor | |||
| 0.066 | 0.017 | 0.066 | Oleamide hydrolase inhibitor | |||
| 0.063 | 0.014 | 0.063 | Progesterone antagonist | 0.062 0.014 CID_6452830 | ||
| 0.059 | 0.011 | 0.059 | Dihydrofolate reductase inhibitor | 0.049 0.02 CID_6452830 | ||
| 0.108 | 0.059 | 0.108 | Alpha 2c adrenoreceptor antagonist | |||
| 0.086 | 0.038 | 0.086 | HIV-1 reverse transcriptase inhibitor | 0.065 0.054 CID_6452830 | ||
| 0.071 | 0.023 | 0.071 | Phosphodiesterase 1A inhibitor | |||
| 0.057 | 0.008 | 0.093 | Glucagon receptor antagonist | 0.093 0.005 CID_6452830 | CID_6452830 | |
| 0.061 | 0.013 | 0.061 | Geranyltranstransferase inhibitor | 0.042 0.033 CID_6452830 | ||
| 0.074 | 0.027 | 0.074 | Phosphodiesterase 1B inhibitor | |||
| 0.089 | 0.042 | 0.089 | Thioredoxin reductase inhibitor | |||
| 0.052 | 0.004 | 0.052 | Integrin alpha2beta1 antagonist | 0.032 0.01 CID_6452830 | ||
| 0.075 | 0.028 | 0.075 | Beta 3 adrenoreceptor antagonist | 0.074 0.029 CID_6452830 | ||
| 0.074 | 0.027 | 0.074 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.078 | 0.031 | 0.078 | Potassium channel (ATP-sensitive) blocker | |||
| 0.068 | 0.021 | 0.068 | AMPA receptor antagonist | |||
| 0.058 | 0.012 | 0.08 | Phosphoglycerate kinase inhibitor | 0.08 0.008 CID_6452830 | CID_6452830 | |
| 0.057 | 0.011 | 0.057 | Fumarate hydratase inhibitor | 0.039 0.019 CID_6452830 | ||
| 0.067 | 0.02 | 0.067 | Lysine-specific demethylase 1A inhibitor | |||
| 0.056 | 0.01 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.063 | 0.017 | 0.063 | Histamine H4 receptor antagonist | |||
| 0.052 | 0.006 | 0.052 | Sodium/glucose cotransporter 2 inhibitor | 0.048 0.007 CID_6452830 | ||
| 0.08 | 0.034 | 0.086 | Peroxisome proliferator-activated receptor gamma antagonist | 0.086 0.026 CID_6452830 | CID_6452830 | |
| 0.082 | 0.037 | 0.082 | Alpha adrenoreceptor agonist | |||
| 0.062 | 0.017 | 0.062 | CC chemokine receptor 2B antagonist | |||
| 0.135 | 0.09 | 0.135 | Insulin secretagoues | |||
| 0.057 | 0.012 | 0.057 | Glutamate (mGluR group II) antagonist | 0.047 0.018 CID_6452830 | ||
| 0.062 | 0.017 | 0.062 | Secretase gamma inhibitor | |||
| 0.054 | 0.009 | 0.054 | Glutamate (mGluR8) agonist | 0.048 0.013 CID_6452830 | ||
| 0.115 | 0.07 | 0.115 | Anesthetic local | |||
| 0.049 | 0.004 | 0.049 | Imidazoline I1 receptor antagonist | |||
| 0.062 | 0.018 | 0.062 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.058 | 0.014 | 0.058 | Guanylate cyclase inhibitor | 0.045 0.027 CID_6452830 | ||
| 0.069 | 0.025 | 0.069 | CC chemokine 2 receptor antagonist | 0.05 0.044 CID_6452830 | ||
| 0.103 | 0.059 | 0.389 | Estrogen receptor beta antagonist | 0.389 0.004 CID_6452830 | CID_6452830 | |
| 0.088 | 0.045 | 0.088 | Cell adhesion molecule inhibitor | |||
| 0.177 | 0.134 | 0.177 | Immunostimulant | 0.161 0.145 CID_6452830 | ||
| 0.048 | 0.005 | 0.048 | Thymidine phosphorylase inhibitor | 0.031 0.011 CID_6452830 | ||
| 0.077 | 0.034 | 0.077 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.051 | 0.009 | 0.051 | Free fatty acid receptor 1 antagonist | 0.038 0.018 CID_6452830 | ||
| 0.069 | 0.027 | 0.069 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.09 | 0.048 | 0.09 | I kappa B kinase inhibitor | 0.085 0.054 CID_6452830 | ||
| 0.079 | 0.037 | 0.079 | Orexin receptor 1 antagonist | |||
| 0.111 | 0.069 | 0.111 | Calcium channel (voltage-sensitive) blocker | |||
| 0.092 | 0.051 | 0.092 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.069 | 0.028 | 0.069 | Calcium channel T-type blocker | |||
| 0.082 | 0.041 | 0.082 | Nav1.8 sodium channel blocker | |||
| 0.108 | 0.067 | 0.108 | Mucolytic | 0.1 0.078 CID_6452830 | ||
| 0.045 | 0.005 | 0.045 | Purinergic P2Y15 antagonist | 0.036 0.009 CID_6452830 | ||
| 0.054 | 0.013 | 0.054 | Acid-sensing ion channel blocker | |||
| 0.061 | 0.021 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.261 | 0.221 | 0.294 | MAP kinase 1 inhibitor | 0.294 0.187 CID_6452830 | CID_6452830 | |
| 0.044 | 0.004 | 0.044 | Hedgehog signaling activator | 0.035 0.007 CID_6452830 | ||
| 0.063 | 0.024 | 0.063 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.055 | 0.016 | 0.055 | Thymidine kinase inhibitor | 0.046 0.022 CID_6452830 | ||
| 0.112 | 0.072 | 0.112 | Cell adhesion inhibitor | |||
| 0.046 | 0.007 | 0.046 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.076 | 0.037 | 0.076 | Protein kinase C beta inhibitor | |||
| 0.046 | 0.008 | 0.046 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.063 | 0.024 | 0.063 | Thromboxane synthase inhibitor | 0.051 0.047 CID_6452830 | ||
| 0.052 | 0.014 | 0.052 | TRPM8 blocker | |||
| 0.064 | 0.026 | 0.064 | MAP kinase kinase 9 inhibitor | |||
| 0.065 | 0.027 | 0.065 | Bcl-xL inhibitor | 0.058 0.046 CID_6452830 | ||
| 0.07 | 0.032 | 0.07 | I kappa B kinase 2 inhibitor | 0.062 0.044 CID_6452830 | ||
| 0.058 | 0.021 | 0.058 | Farnesyltransferase inhibitor | |||
| 0.083 | 0.046 | 0.083 | Alpha 2a adrenoreceptor antagonist | |||
| 0.052 | 0.014 | 0.052 | Vascular adhesion protein 1 inhibitor | |||
| 0.059 | 0.022 | 0.059 | Potassium channel Kv1.3 blocker | 0.045 0.035 CID_6452830 | ||
| 0.154 | 0.117 | 0.154 | Death-associated protein kinase 3 inhibitor | 0.143 0.133 CID_6452830 | ||
| 0.049 | 0.012 | 0.093 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.093 0.004 CID_6452830 | CID_6452830 | |
| 0.043 | 0.006 | 0.043 | 5 Hydroxytryptamine 6 agonist | |||
| 0.068 | 0.032 | 0.068 | Acetylcholine M5 receptor antagonist | |||
| 0.041 | 0.005 | 0.041 | Glutamate (mGluR1a) agonist | 0.02 0.019 CID_6452830 | ||
| 0.042 | 0.006 | 0.042 | MAP3K8 inhibitor | |||
| 0.046 | 0.01 | 0.046 | Carnitine palmitoyltransferase inhibitor | |||
| 0.041 | 0.005 | 0.041 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.046 | 0.01 | 0.046 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.12 | 0.085 | 0.243 | Interleukin 4 antagonist | 0.243 0.014 CID_6452830 | CID_6452830 | |
| 0.061 | 0.026 | 0.061 | Leukotriene C antagonist | 0.058 0.034 CID_6452830 | ||
| 0.043 | 0.008 | 0.043 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.048 | 0.013 | 0.048 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.045 | 0.01 | 0.045 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.017 CID_6452830 | ||
| 0.089 | 0.056 | 0.089 | Acetylcholine agonist | |||
| 0.09 | 0.056 | 0.09 | Ca(v)2.2 blocker | |||
| 0.075 | 0.041 | 0.075 | Neuronal nicotinic receptor antagonist | |||
| 0.093 | 0.06 | 0.093 | ABCA1 expression enhancer | |||
| 0.061 | 0.027 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.014 CID_6452830 | CID_6452830 | |
| 0.038 | 0.005 | 0.038 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 CID_6452830 | ||
| 0.037 | 0.004 | 0.037 | Complement factor 1s inhibitor | 0.025 0.019 CID_6452830 | ||
| 0.04 | 0.007 | 0.04 | Sodium/glucose cotransporter inhibitor | 0.037 0.008 CID_6452830 | ||
| 0.038 | 0.005 | 0.038 | Complement factor 1r inhibitor | |||
| 0.05 | 0.017 | 0.05 | Angiotensin AT1 receptor antagonist | |||
| 0.043 | 0.01 | 0.043 | Uridine phosphorylase inhibitor | 0.025 0.023 CID_6452830 | ||
| 0.066 | 0.033 | 0.066 | Glutamate (mGluR1) antagonist | |||
| 0.052 | 0.02 | 0.052 | Histamine H2 receptor agonist | |||
| 0.051 | 0.018 | 0.081 | Urate transporter 1 inhibitor | 0.081 0.008 CID_6452830 | CID_6452830 | |
| 0.074 | 0.041 | 0.089 | Leukotriene synthesis inhibitor | 0.089 0.032 CID_6452830 | CID_6452830 | |
| 0.231 | 0.199 | 0.25 | Alpha-glucosidase inhibitor | 0.25 0.188 CID_6452830 | CID_6452830 | |
| 0.083 | 0.051 | 0.112 | Topoisomerase II alpha inhibitor | 0.112 0.033 CID_6452830 | CID_6452830 | |
| 0.058 | 0.026 | 0.058 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.067 | 0.036 | 0.067 | Prostaglandin F2 alpha antagonist | |||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.083 | 0.052 | 0.083 | Ca(v)3.1 blocker | |||
| 0.043 | 0.012 | 0.043 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.044 | 0.013 | 0.044 | Glutamate (mGluR4) agonist | 0.031 0.03 CID_6452830 | ||
| 0.053 | 0.022 | 0.053 | Cytokine production stimulant | |||
| 0.042 | 0.011 | 0.042 | Glutamate (mGluR2) antagonist | 0.033 0.017 CID_6452830 | ||
| 0.054 | 0.023 | 0.054 | Thymidylate synthase inhibitor | 0.053 0.024 CID_6452830 | ||
| 0.039 | 0.008 | 0.039 | CXC chemokine 2 receptor antagonist | 0.036 0.009 CID_6452830 | ||
| 0.084 | 0.053 | 0.116 | Adrenaline agonist | 0.116 0.027 CID_6452830 | CID_6452830 | |
| 0.035 | 0.005 | 0.035 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.01 CID_6452830 | ||
| 0.058 | 0.028 | 0.058 | Factor IXa inhibitor | 0.049 0.04 CID_6452830 | ||
| 0.071 | 0.041 | 0.071 | Cannabinoid receptor agonist | |||
| 0.085 | 0.055 | 0.085 | GABA A receptor agonist | |||
| 0.072 | 0.042 | 0.072 | CDC7 inhibitor | |||
| 0.059 | 0.029 | 0.059 | Alpha-mannosidase inhibitor | |||
| 0.125 | 0.095 | 0.125 | Aurora-C kinase inhibitor | |||
| 0.053 | 0.023 | 0.053 | Carbonic anhydrase IV inhibitor | |||
| 0.043 | 0.014 | 0.047 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.047 0.01 CID_6452830 | CID_6452830 | |
| 0.06 | 0.031 | 0.06 | Nicotinic alpha7 receptor agonist | |||
| 0.082 | 0.053 | 0.082 | Acetylcholine nicotinic antagonist | |||
| 0.087 | 0.059 | 0.087 | Ornithine decarboxylase inhibitor | |||
| 0.041 | 0.013 | 0.041 | AMPA 3 receptor antagonist | |||
| 0.045 | 0.017 | 0.061 | Nicotinic acid receptor agonist | 0.061 0.011 CID_6452830 | CID_6452830 | |
| 0.043 | 0.014 | 0.043 | Purinergic P2X3 antagonist | 0.032 0.029 CID_6452830 | ||
| 0.083 | 0.055 | 0.083 | Histamine H1 receptor antagonist | |||
| 0.033 | 0.005 | 0.033 | ICAM 1 antagonist | |||
| 0.047 | 0.02 | 0.047 | Sphingosine kinase 1 inhibitor | |||
| 0.036 | 0.008 | 0.036 | Prostaglandin H2 antagonist | 0.027 0.016 CID_6452830 | ||
| 0.061 | 0.033 | 0.061 | Acetylcholine muscarinic agonist | |||
| 0.106 | 0.079 | 0.106 | Proteasome inhibitor | |||
| 0.049 | 0.022 | 0.054 | CDK5/p25 inhibitor | 0.054 0.019 CID_6452830 | CID_6452830 | |
| 0.051 | 0.024 | 0.051 | CC chemokine 3 receptor antagonist | |||
| 0.061 | 0.034 | 0.061 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.031 | 0.005 | 0.031 | Cyclin T1 inhibitor | |||
| 0.034 | 0.008 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.011 CID_6452830 | ||
| 0.063 | 0.037 | 0.073 | Beta 2 adrenoreceptor agonist | 0.073 0.015 CID_6452830 | CID_6452830 | |
| 0.074 | 0.048 | 0.074 | Epoxide hydrolase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.005 CID_6452830 | ||
| 0.036 | 0.01 | 0.036 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.079 | 0.054 | 0.079 | Interferon agonist | |||
| 0.065 | 0.04 | 0.065 | Phosphodiesterase VII inhibitor | |||
| 0.062 | 0.036 | 0.062 | Carbonic anhydrase IX inhibitor | |||
| 0.049 | 0.024 | 0.049 | AICAR transformylase inhibitor | |||
| 0.06 | 0.035 | 0.06 | Nicotinic neuronal receptor agonist | |||
| 0.028 | 0.004 | 0.028 | Thromboxane A2 agonist | 0.02 0.005 CID_6452830 | ||
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | |||
| 0.039 | 0.014 | 0.039 | Adenosine uptake inhibitor | |||
| 0.033 | 0.008 | 0.033 | Geranylgeranyltransferase inhibitor | |||
| 0.051 | 0.026 | 0.055 | Carbonic anhydrase VII inhibitor | 0.055 0.023 CID_6452830 | CID_6452830 | |
| 0.029 | 0.004 | 0.029 | Complement factor D inhibitor | 0.017 0.015 CID_6452830 | ||
| 0.098 | 0.073 | 0.099 | Toll-Like receptor 4 antagonist | 0.099 0.071 CID_6452830 | CID_6452830 | |
| 0.029 | 0.005 | 0.029 | Alpha 2b adrenoreceptor agonist | 0.018 0.014 CID_6452830 | ||
| 0.043 | 0.019 | 0.043 | Glycine transporter 1 inhibitor | |||
| 0.027 | 0.003 | 0.027 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 CID_6452830 | ||
| 0.029 | 0.005 | 0.029 | Alpha 2c adrenoreceptor agonist | |||
| 0.038 | 0.014 | 0.038 | Cholesterol ester transfer protein antagonist | 0.029 0.026 CID_6452830 | ||
| 0.053 | 0.029 | 0.053 | Bombesin 2 receptor antagonist | |||
| 0.044 | 0.02 | 0.044 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.144 | 0.12 | 0.144 | Clk dual-specificity kinase inhibitor | |||
| 0.066 | 0.042 | 0.066 | CDC25B inhibitor | 0.062 0.048 CID_6452830 | ||
| 0.068 | 0.044 | 0.068 | Orexin receptor antagonist | |||
| 0.056 | 0.033 | 0.056 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.031 | 0.008 | 0.031 | Acid ceramidase inhibitor | |||
| 0.062 | 0.038 | 0.062 | Potassium channel (Ca-activated) blocker | |||
| 0.042 | 0.018 | 0.042 | Retinoid X alpha receptor agonist | 0.035 0.024 CID_6452830 | ||
| 0.061 | 0.037 | 0.069 | EphB4 antagonist | 0.069 0.03 CID_6452830 | CID_6452830 | |
| 0.053 | 0.03 | 0.053 | Carbonic anhydrase XIV inhibitor | 0.047 0.036 CID_6452830 | ||
| 0.027 | 0.004 | 0.027 | CC chemokine 9 receptor antagonist | 0.019 0.009 CID_6452830 | ||
| 0.048 | 0.026 | 0.16 | Estradiol 17 beta-dehydrogenase inhibitor | 0.16 0.005 CID_6452830 | CID_6452830 | |
| 0.033 | 0.011 | 0.033 | Calcium-sensing receptor agonist | |||
| 0.027 | 0.005 | 0.027 | Nicotinic acid receptor 1 antagonist | 0.027 0.005 CID_6452830 | ||
| 0.044 | 0.022 | 0.044 | Dihydropteroate synthase inhibitor | |||
| 0.057 | 0.034 | 0.057 | Toll-Like receptor 8 antagonist | |||
| 0.059 | 0.037 | 0.059 | Alpha 1 adrenoreceptor agonist | |||
| 0.056 | 0.034 | 0.056 | Ornithine carbamoyltransferase inhibitor | |||
| 0.228 | 0.206 | 0.228 | DNA directed DNA polymerase inhibitor | |||
| 0.042 | 0.02 | 0.042 | VCAM-1 antagonist | |||
| 0.054 | 0.032 | 0.054 | Phosphodiesterase 7A inhibitor | |||
| 0.042 | 0.02 | 0.042 | VCAM antagonist | |||
| 0.031 | 0.01 | 0.031 | Kainate receptor 1 antagonist | |||
| 0.038 | 0.017 | 0.038 | Calcium release-activated channel blocker | |||
| 0.065 | 0.043 | 0.065 | Interferon inducer | |||
| 0.033 | 0.011 | 0.047 | CC chemokine 1 receptor antagonist | 0.047 0.007 CID_6452830 | CID_6452830 | |
| 0.038 | 0.016 | 0.038 | Dipeptidyl peptidase II inhibitor | |||
| 0.042 | 0.021 | 0.042 | Potassium channel KCNQ activator | |||
| 0.042 | 0.021 | 0.042 | Delayed rectifier potassium channel activator | |||
| 0.047 | 0.026 | 0.047 | Liver X receptor agonist | 0.043 0.031 CID_6452830 | ||
| 0.028 | 0.007 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.024 0.012 CID_6452830 | ||
| 0.026 | 0.006 | 0.026 | G-protein-coupled receptor 120 agonist | 0.021 0.008 CID_6452830 | ||
| 0.034 | 0.014 | 0.043 | Liver X receptor alpha antagonist | 0.043 0.008 CID_6452830 | CID_6452830 | |
| 0.059 | 0.039 | 0.088 | Xanthine dehydrogenase inhibitor | 0.088 0.02 CID_6452830 | CID_6452830 | |
| 0.055 | 0.035 | 0.055 | NMDA 2B receptor antagonist | 0.053 0.038 CID_6452830 | ||
| 0.053 | 0.033 | 0.053 | Prolyl endopeptidase inhibitor | |||
| 0.087 | 0.067 | 0.087 | Thioredoxin inhibitor | 0.081 0.08 CID_6452830 | ||
| 0.043 | 0.023 | 0.043 | Melanocortin 1 antagonist | |||
| 0.133 | 0.113 | 0.196 | Dual specificity phosphatase 3 inhibitor | 0.196 0.063 CID_6452830 | CID_6452830 | |
| 0.041 | 0.021 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | 0.034 0.029 CID_6452830 | ||
| 0.029 | 0.009 | 0.029 | Prostaglandin F2 alpha agonist | 0.025 0.013 CID_6452830 | ||
| 0.036 | 0.017 | 0.036 | AMPA 1 receptor antagonist | |||
| 0.031 | 0.012 | 0.031 | Prostaglandin EP2 agonist | 0.02 0.018 CID_6452830 | ||
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | 0.057 0.048 CID_6452830 | ||
| 0.082 | 0.063 | 0.082 | Alpha 2 adrenoreceptor antagonist | |||
| 0.071 | 0.053 | 0.071 | Lipase inhibitor | |||
| 0.095 | 0.076 | 0.095 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.038 | 0.02 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 CID_6452830 | CID_6452830 | |
| 0.105 | 0.086 | 0.347 | Estrogen antagonist | 0.347 0.005 CID_6452830 | CID_6452830 | |
| 0.075 | 0.056 | 0.077 | Keratolytic | 0.077 0.053 CID_6452830 | CID_6452830 | |
| 0.085 | 0.066 | 0.085 | Pim-3 kinase inhibitor | |||
| 0.072 | 0.053 | 0.072 | CDC25A inhibitor | 0.071 0.055 CID_6452830 | ||
| 0.046 | 0.027 | 0.046 | Oxytocin agonist | 0.04 0.031 CID_6452830 | ||
| 0.022 | 0.003 | 0.022 | Progesterone receptor A antagonist | 0.015 0.004 CID_6452830 | ||
| 0.04 | 0.022 | 0.04 | Arginase inhibitor | |||
| 0.068 | 0.05 | 0.068 | Elastase 1 inhibitor | |||
| 0.052 | 0.034 | 0.052 | Glucose-6-phosphate translocase inhibitor | 0.048 0.044 CID_6452830 | ||
| 0.035 | 0.017 | 0.035 | Glutamate (mGluR3) agonist | 0.034 0.018 CID_6452830 | ||
| 0.051 | 0.033 | 0.051 | Transforming growth factor beta 1 antagonist | |||
| 0.056 | 0.038 | 0.056 | Carbonic anhydrase I inhibitor | |||
| 0.022 | 0.005 | 0.022 | Integrin beta2 antagonist | |||
| 0.046 | 0.028 | 0.046 | Acetylcholine M1 receptor agonist | |||
| 0.116 | 0.099 | 0.116 | CDC-like kinase 1 inhibitor | |||
| 0.086 | 0.069 | 0.086 | Polo-like kinase-1 inhibitor | |||
| 0.037 | 0.019 | 0.037 | Angiotensin II receptor antagonist | |||
| 0.053 | 0.036 | 0.053 | Autotaxin inhibitor | |||
| 0.035 | 0.018 | 0.043 | Liver X receptor antagonist | 0.043 0.012 CID_6452830 | CID_6452830 | |
| 0.027 | 0.011 | 0.027 | Prostaglandin EP1 antagonist | |||
| 0.039 | 0.023 | 0.039 | Integrin alpha1beta1 antagonist | |||
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.034 | 0.018 | 0.034 | CXC chemokine 3 receptor antagonist | |||
| 0.034 | 0.017 | 0.034 | Epoxide hydrolase 1 inhibitor | |||
| 0.028 | 0.012 | 0.028 | Vanilloid 2 agonist | 0.025 0.017 CID_6452830 | ||
| 0.04 | 0.024 | 0.04 | Leukotriene C4 antagonist | 0.038 0.031 CID_6452830 | ||
| 0.034 | 0.018 | 0.034 | Prostaglandin agonist | |||
| 0.031 | 0.015 | 0.031 | Estrogen-related receptor gamma antagonist | 0.029 0.017 CID_6452830 | ||
| 0.02 | 0.004 | 0.02 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.038 | 0.023 | 0.038 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.03 | 0.015 | 0.03 | Urotensin II agonist | |||
| 0.053 | 0.038 | 0.053 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.063 | 0.048 | 0.065 | Leukotriene antagonist | 0.065 0.045 CID_6452830 | CID_6452830 | |
| 0.047 | 0.032 | 0.047 | Glutamate (mGluR5) antagonist | |||
| 0.06 | 0.046 | 0.06 | Carbonic anhydrase inhibitor | 0.053 0.052 CID_6452830 | ||
| 0.051 | 0.037 | 0.051 | Carbonic anhydrase XII inhibitor | |||
| 0.045 | 0.031 | 0.045 | Mannosidase inhibitor | |||
| 0.054 | 0.04 | 0.054 | Carbonic anhydrase II inhibitor | |||
| 0.034 | 0.02 | 0.054 | Estrogen-related receptor beta antagonist | 0.054 0.005 CID_6452830 | CID_6452830 | |
| 0.039 | 0.025 | 0.039 | G protein-coupled receptor agonist | |||
| 0.021 | 0.008 | 0.021 | CXC chemokine 5 receptor antagonist | |||
| 0.032 | 0.019 | 0.032 | Prostaglandin EP3 antagonist | |||
| 0.059 | 0.046 | 0.059 | Dopamine D3 antagonist | |||
| 0.021 | 0.008 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.049 | 0.036 | 0.049 | Sodium/calcium exchanger inhibitor | |||
| 0.089 | 0.076 | 0.089 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.102 | 0.089 | 0.102 | Acetylcholine muscarinic antagonist | 0.097 0.094 CID_6452830 | ||
| 0.139 | 0.127 | 0.153 | Interleukin antagonist | 0.153 0.115 CID_6452830 | CID_6452830 | |
| 0.044 | 0.031 | 0.055 | Sphingosine 1-phosphate receptor agonist | 0.055 0.021 CID_6452830 | CID_6452830 | |
| 0.057 | 0.044 | 0.057 | Carbonic anhydrase stimulant | |||
| 0.017 | 0.005 | 0.017 | Carbonic anhydrase XI inhibitor | |||
| 0.027 | 0.015 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.056 | 0.043 | 0.056 | Cathepsin L inhibitor | |||
| 0.044 | 0.032 | 0.044 | Purinergic P2Y antagonist | |||
| 0.042 | 0.03 | 0.051 | Sphingosine 1-phosphate receptor 1 agonist | 0.051 0.019 CID_6452830 | CID_6452830 | |
| 0.027 | 0.016 | 0.042 | Thyroid hormone agonist | 0.042 0.005 CID_6452830 | CID_6452830 | |
| 0.038 | 0.026 | 0.038 | DNA gyrase subunit B inhibitor | |||
| 0.051 | 0.04 | 0.051 | Dipeptidyl peptidase inhibitor | |||
| 0.061 | 0.05 | 0.061 | Neutrophil collagenase inhibitor | |||
| 0.026 | 0.015 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.046 | 0.035 | 0.046 | Adenosine deaminase inhibitor | |||
| 0.026 | 0.015 | 0.026 | Dopamine autoreceptor agonist | |||
| 0.022 | 0.011 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.039 | 0.028 | 0.039 | Cathepsin L1 inhibitor | |||
| 0.038 | 0.028 | 0.038 | MAP3K5 inhibitor | |||
| 0.025 | 0.014 | 0.025 | Prostaglandin E2 agonist | |||
| 0.024 | 0.013 | 0.024 | Adenosine kinase inhibitor | |||
| 0.05 | 0.04 | 0.05 | Histamine agonist | |||
| 0.039 | 0.029 | 0.039 | Erythropoietin receptor agonist | |||
| 0.033 | 0.023 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.018 | 0.009 | 0.018 | Nicotinic alpha4 receptor agonist | |||
| 0.018 | 0.008 | 0.018 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_6452830 | ||
| 0.012 | 0.003 | 0.012 | DNA topoisomerase III inhibitor | 0.008 0.005 CID_6452830 | ||
| 0.043 | 0.034 | 0.043 | Dipeptidyl peptidase IV inhibitor | |||
| 0.068 | 0.059 | 0.068 | Vanilloid antagonist | |||
| 0.015 | 0.005 | 0.015 | Egl nine homolog 3 inhibitor | 0.013 0.008 CID_6452830 | ||
| 0.014 | 0.005 | 0.014 | Thromboxane agonist | |||
| 0.056 | 0.047 | 0.056 | Cyclin A1 inhibitor | |||
| 0.043 | 0.034 | 0.043 | Factor Xa inhibitor | |||
| 0.013 | 0.004 | 0.013 | Corticotropin releasing factor antagonist | |||
| 0.021 | 0.013 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.022 0.013 CID_6452830 | CID_6452830 | |
| 0.073 | 0.064 | 0.073 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.03 | 0.022 | 0.03 | Acetylcholine M4 receptor agonist | |||
| 0.059 | 0.051 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.136 | 0.128 | 0.136 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.039 | 0.031 | 0.039 | Glutamate (mGluR1a) antagonist | |||
| 0.035 | 0.028 | 0.035 | Somatostatin 4 agonist | |||
| 0.037 | 0.03 | 0.037 | Histone deacetylase 9 inhibitor | |||
| 0.028 | 0.02 | 0.028 | Thrombin receptor antagonist | |||
| 0.011 | 0.004 | 0.011 | Free fatty acid receptor 2 antagonist | |||
| 0.043 | 0.036 | 0.043 | Glycine transporter 2 inhibitor | |||
| 0.068 | 0.061 | 0.068 | Metalloproteinase-9 inhibitor | |||
| 0.036 | 0.03 | 0.036 | Retinoid X receptor antagonist | |||
| 0.03 | 0.023 | 0.035 | HCV NS5B polymerase inhibitor | 0.035 0.018 CID_6452830 | CID_6452830 | |
| 0.032 | 0.025 | 0.032 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.018 | 0.011 | 0.018 | Sodium/hydrogen exchanger inhibitor | |||
| 0.033 | 0.026 | 0.033 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.036 | 0.03 | 0.036 | Antidiuretic hormone antagonist | |||
| 0.017 | 0.011 | 0.017 | Telomerase stimulant | 0.016 0.014 CID_6452830 | ||
| 0.033 | 0.027 | 0.033 | Retinoid X receptor agonist | |||
| 0.034 | 0.028 | 0.034 | Histone deacetylase 7 inhibitor | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase VIII inhibitor | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase X inhibitor | |||
| 0.027 | 0.022 | 0.027 | Cyclin E2 inhibitor | |||
| 0.02 | 0.015 | 0.02 | Integrin alpha4beta7 antagonist | |||
| 0.048 | 0.043 | 0.048 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.037 | 0.032 | 0.037 | Histone deacetylase 8 inhibitor | |||
| 0.012 | 0.007 | 0.012 | Melatonin 5 antagonist | |||
| 0.037 | 0.032 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.024 | 0.02 | 0.024 | Prostaglandin EP4 antagonist | |||
| 0.031 | 0.027 | 0.031 | Purinergic P2Y2 antagonist | |||
| 0.064 | 0.059 | 0.064 | CXC chemokine receptor antagonist | |||
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.008 | 0.004 | 0.008 | CC chemokine 6 receptor agonist | |||
| 0.053 | 0.048 | 0.053 | Prostaglandin EP2 antagonist | |||
| 0.032 | 0.028 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.048 | 0.044 | 0.048 | Cannabinoid CB2 receptor agonist | |||
| 0.013 | 0.009 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.037 | 0.033 | 0.037 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.037 | 0.033 | 0.037 | Smo receptor antagonist | |||
| 0.07 | 0.066 | 0.07 | Metalloproteinase-2 inhibitor | |||
| 0.018 | 0.015 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.073 | 0.07 | 0.073 | Phosphodiesterase IV inhibitor | |||
| 0.02 | 0.017 | 0.02 | Factor XIII inhibitor | |||
| 0.216 | 0.213 | 0.216 | DNA polymerase beta inhibitor | |||
| 0.038 | 0.035 | 0.038 | Plasmepsin II inhibitor | |||
| 0.012 | 0.01 | 0.012 | Integrin alphaLbeta2 antagonist | |||
| 0.049 | 0.047 | 0.049 | Beta 1 adrenoreceptor antagonist | |||
| 0.017 | 0.015 | 0.017 | Histamine H4 receptor agonist | |||
| 0.015 | 0.013 | 0.015 | CDK2/cyclin A3 inhibitor | |||
| 0.02 | 0.018 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.013 | 0.011 | 0.013 | Prostaglandin EP4 agonist | |||
| 0.043 | 0.042 | 0.043 | Metalloproteinase-3 inhibitor | |||
| 0.026 | 0.024 | 0.026 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.014 | 0.013 | 0.014 | Purinergic P2Y1 agonist | |||
| 0.019 | 0.018 | 0.019 | Aggrecanase 2 inhibitor | |||
| 0.039 | 0.037 | 0.039 | Cathepsin F inhibitor | |||
| 0.043 | 0.041 | 0.05 | Beta adrenoreceptor agonist | 0.05 0.018 CID_6452830 | CID_6452830 | |
| 0.068 | 0.067 | 0.071 | Phosphodiesterase VI inhibitor | 0.071 0.059 CID_6452830 | CID_6452830 | |
| 0.032 | 0.03 | 0.032 | Orexin receptor 2 antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.086 | 0.085 | 0.086 | Insulin receptor antagonist | |||
| 0.03 | 0.029 | 0.03 | Vanilloid 4 antagonist | |||
| 0.033 | 0.032 | 0.033 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.029 | 0.028 | 0.029 | Vasopressin 2 antagonist | |||
| 0.019 | 0.019 | 0.083 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.083 0.004 CID_6452830 | CID_6452830 | |
| 0.023 | 0.022 | 0.023 | 5 Hydroxytryptamine 4 agonist | |||
| 0.018 | 0.017 | 0.018 | Kainate receptor 5 antagonist | |||
| 0.026 | 0.025 | 0.026 | Glucosylceramidase stimulant | |||
| 0.126 | 0.126 | 0.159 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.159 0.058 CID_6452830 | CID_6452830 | |
| 0.02 | 0.02 | 0.022 | Beta 1 adrenoreceptor agonist | 0.022 0.017 CID_6452830 | CID_6452830 | |
| 0.011 | 0.011 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 CID_6452830 | CID_6452830 | |
| 0.013 | 0.013 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.01 CID_6452830 | CID_6452830 | |
| 0.086 | 0.087 | 0.106 | Monophenol monooxygenase inhibitor | 0.106 0.071 CID_6452830 | CID_6452830 | |
| 0.061 | 0.062 | 0.084 | Dopamine antagonist | 0.084 0.045 CID_6452830 | CID_6452830 | |
| 0.058 | 0.06 | 0.065 | Beta adrenoreceptor antagonist | 0.065 0.047 CID_6452830 | CID_6452830 | |
| 0.081 | 0.083 | 0.109 | Ephrin antagonist | 0.109 0.057 CID_6452830 | CID_6452830 | |
| 0.033 | 0.037 | 0.037 | Dopamine D3 agonist | 0.037 0.03 CID_6452830 | CID_6452830 | |
| 0.004 | 0.009 | 0.01 | Insulin like growth factor 3 antagonist | 0.01 0.003 CID_6452830 | CID_6452830 | |
| 0.006 | 0.011 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 CID_6452830 | CID_6452830 | |
| 0.042 | 0.049 | 0.045 | Beta 2 adrenoreceptor antagonist | 0.045 0.043 CID_6452830 | CID_6452830 | |
| 0.075 | 0.087 | 0.145 | 5-Lipoxygenase inhibitor | 0.145 0.039 CID_6452830 | CID_6452830 | |
| 0.049 | 0.063 | 0.076 | Dopamine agonist | 0.076 0.04 CID_6452830 | CID_6452830 | |
| 0.046 | 0.061 | 0.054 | Acetylcholine M3 receptor antagonist | 0.054 0.048 CID_6452830 | CID_6452830 | |
| 0.075 | 0.091 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.072 CID_6452830 | CID_6452830 | |
| 0.086 | 0.103 | 0.211 | c-Src kinase inhibitor | 0.211 0.032 CID_6452830 | CID_6452830 | |
| 0.045 | 0.063 | 0.059 | Dopamine D2 antagonist | 0.059 0.05 CID_6452830 | CID_6452830 | |
| 0.134 | 0.153 | 0.205 | Dyrk kinase inhibitor | 0.205 0.096 CID_6452830 | CID_6452830 | |
| 0.041 | 0.061 | 0.055 | CXC chemokine 1 receptor antagonist | 0.055 0.029 CID_6452830 | CID_6452830 | |
| 0.119 | 0.14 | 0.175 | Dual specificity phosphatase inhibitor | 0.175 0.071 CID_6452830 | CID_6452830 | |
| 0.13 | 0.153 | 0.21 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.21 0.086 CID_6452830 | CID_6452830 | |
| 0.015 | 0.04 | 0.119 | Estrogen receptor alpha agonist | 0.119 0.007 CID_6452830 | CID_6452830 | |
| 0.021 | 0.049 | 0.029 | Estrogen-related receptor alpha antagonist | 0.029 0.027 CID_6452830 | CID_6452830 | |
| 0.101 | 0.13 | 0.172 | Src kinase inhibitor | 0.172 0.07 CID_6452830 | CID_6452830 | |
| 0.02 | 0.049 | 0.196 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.196 0.004 CID_6452830 | CID_6452830 | |
| 0.01 | 0.047 | 0.021 | Thyroid hormone alpha agonist | 0.021 0.006 CID_6452830 | CID_6452830 | |
| 0.084 | 0.124 | 0.113 | Epidermal growth factor receptor kinase inhibitor | 0.113 0.08 CID_6452830 | CID_6452830 | |
| 0.118 | 0.158 | 0.137 | MAP kinase kinase 4 inhibitor | 0.137 0.092 CID_6452830 | CID_6452830 | |
| 0.069 | 0.111 | 0.136 | Uric acid excretion stimulant | 0.136 0.029 CID_6452830 | CID_6452830 | |
| 0.101 | 0.149 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.103 CID_6452830 | CID_6452830 | |
| 0.019 | 0.07 | 0.106 | Dopamine D5 antagonist | 0.106 0.009 CID_6452830 | CID_6452830 | |
| 0.008 | 0.07 | 0.176 | Estrogen receptor beta agonist | 0.176 0.005 CID_6452830 | CID_6452830 | |
| 0.025 | 0.102 | 0.054 | Alpha tubulin antagonist | 0.054 0.036 CID_6452830 | CID_6452830 | |
| 0.015 | 0.093 | 0.19 | Estrogen agonist | 0.19 0.009 CID_6452830 | CID_6452830 | |
| 0.014 | 0.096 | 0.045 | Catechol O-methyltransferase inhibitor | 0.045 0.011 CID_6452830 | CID_6452830 | |
| 0.167 | 0.254 | 0.219 | Interleukin 2 agonist | 0.219 0.158 CID_6452830 | CID_6452830 | |
| 0.044 | 0.135 | 0.1 | HIV-1 integrase inhibitor | 0.1 0.025 CID_6452830 | CID_6452830 | |
| 0.019 | 0.112 | 0.059 | Beta tubulin antagonist | 0.059 0.04 CID_6452830 | CID_6452830 | |
| 0.006 | 0.104 | 0.019 | Thyroid hormone alpha antagonist | 0.019 0.008 CID_6452830 | CID_6452830 | |
| 0.03 | 0.139 | 0.078 | HIV-1 integrase (3'-Processing) inhibitor | 0.078 0.034 CID_6452830 | CID_6452830 | |
| 0.053 | 0.163 | 0.104 | Topoisomerase II inhibitor | 0.104 0.082 CID_6452830 | CID_6452830 | |
| 0.079 | 0.19 | 0.166 | Protein-tyrosine phosphatase inhibitor | 0.166 0.065 CID_6452830 | CID_6452830 | |
| 0.022 | 0.147 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | 0.065 0.039 CID_6452830 | CID_6452830 | |
| 0.18 | 0.306 | 0.334 | Apoptosis agonist | 0.334 0.149 CID_6452830 | CID_6452830 | |
| 0.008 | 0.146 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CID_6452830 | CID_6452830 | |
| 0.026 | 0.199 | 0.109 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.109 0.03 CID_6452830 | CID_6452830 | |
| 0.038 | 0.226 | 0.06 | Heme oxygenase stimulant | 0.06 0.046 CID_6452830 | CID_6452830 | |
| 0.047 | 0.235 | 0.114 | DNA polymerase I inhibitor | 0.114 0.073 CID_6452830 | CID_6452830 | |
| 0.036 | 0.234 | 0.056 | Lipocortins synthesis agonist | 0.056 0.047 CID_6452830 | CID_6452830 | |
| 0.048 | 0.269 | 0.095 | Vanilloid agonist | 0.095 0.039 CID_6452830 | CID_6452830 | |
| 0.005 | 0.231 | 0.068 | Sphingosine 1-phosphate receptor 3 agonist | 0.068 0.01 CID_6452830 | CID_6452830 | |
| 0.024 | 0.263 | 0.098 | Protein-tyrosine phosphatase 1B inhibitor | 0.098 0.08 CID_6452830 | CID_6452830 | |
| 0.046 | 0.31 | 0.153 | Amyloid beta aggregation inhibitor | 0.153 0.106 CID_6452830 | CID_6452830 | |
| 0.089 | 0.358 | 0.259 | Immunosuppressant | 0.259 0.141 CID_6452830 | CID_6452830 | |
| 0.023 | 0.314 | 0.086 | Topoisomerase I inhibitor | 0.086 0.083 CID_6452830 | CID_6452830 | |
| 0.055 | 0.358 | 0.223 | Free radical scavenger | 0.223 0.082 CID_6452830 | CID_6452830 | |
| 0.04 | 0.45 | 0.126 | Nitric oxide antagonist | 0.126 0.125 CID_6452830 | CID_6452830 | |
| 0.041 | 0.462 | 0.239 | Antioxidant | 0.239 0.09 CID_6452830 | CID_6452830 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |